Facial Injectables | Medtech 360 | Market Analysis | Europe (Supplemental) | 2017
The European facial injectables market will expand through 2025, fueled by high patient demand, economic recovery, product improvements, and an increasing number of practitioners offering these procedures. Nevertheless, tightening regulations and price competition will limit market growth slightly.
The large number of relatively homogeneous products in the market is forcing companies to innovate and increase their focus on promotions and marketing initiatives.
This Medtech 360 Report provides key market metrics and high-level qualitative commentary for facial injectables in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.
